AIMTo present clinical characteristics from renal transplant recipients with dengue fever and its impact on graft function.METHODSWe retrospectively evaluated 11 renal transplant recipients (RTR) with dengue infection confirmed by laboratory test, between January 2007 and July 2012, transplanted in the Renal Transplant Center of Walter Cantídio University Hospital from Federal University of Ceará.RESULTSPositive dengue serology (IgM) was found in all patients. The mean time between transplant and dengue infection was 43 mo. Fever was presented in all patients. Nine patients presented with classical dengue and two (18%) with dengue hemorrhagic fever. All cases had satisfactory evolution with complete recovery of the symptoms. The time for symptom resolution varied from 2 to 20 d, with an average of 9 d. An increase of creatinine after the infection was observed in three (27.2%) patients with no clinically impact on the kidney graft function.CONCLUSIONRTR with dengue infection seems to have a clinical presentation and evolution similar to those seen in the general population, with no long-term damage to patient and to the graft.
Os autores relatam o caso de uma paciente do sexo feminino, 21 anos, com diagnóstico de Síndrome de Ochoa e portadora de Insuficiência Renal Crônica (IRC) dialítica, submetida a transplante renal com doador falecido e sua evolução pós- transplante. O Transplante renal é uma opção segura para pacientes com Síndrome de Ochoa que evoluem para IRC terminal, apesar do risco aumentado de infecção do trato urinário pós-transplante. A ampliação vesical com ou sem derivação urinária externa continente, além do cateterismo vesical intermitente deve ser recomendada para prevenção de dano ao enxerto renal.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.